Detalhe da pesquisa
1.
Adenovirus serotype 5 hexon mediates liver gene transfer.
Cell
; 132(3): 397-409, 2008 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18267072
2.
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Nature
; 441(7090): 239-43, 2006 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-16625206
3.
Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer.
J Virol
; 83(1): 479-83, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18945780
4.
Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.
J Immunol
; 181(6): 4188-98, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18768876
5.
Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
J Virol
; 82(14): 6829-37, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18448519
6.
Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.
Infect Immun
; 76(4): 1709-18, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18212075
7.
The dendritic cell-derived protein DC-STAMP is highly conserved and localizes to the endoplasmic reticulum.
J Leukoc Biol
; 77(3): 337-43, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15601667
8.
Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.
Cancer Gene Ther
; 11(3): 227-36, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14726960
9.
Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.
J Gen Virol
; 90(Pt 7): 1600-1610, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19282435
10.
Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor.
J Gen Virol
; 88(Pt 11): 2925-2934, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947513
11.
Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.
J Immunol
; 179(3): 1721-9, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17641038
12.
High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector.
J Gen Virol
; 88(Pt 11): 2915-2924, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947512
13.
Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D.
J Virol
; 81(7): 3627-31, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17251290
14.
Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.
Vaccine
; 25(8): 1426-36, 2007 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-17161889
15.
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.
J Virol
; 81(9): 4654-63, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17329340
16.
Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.
Vaccine
; 25(35): 6501-10, 2007 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-17646036
17.
Viral vectors for malaria vaccine development.
Vaccine
; 25(14): 2567-74, 2007 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16914237
18.
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.
J Gen Virol
; 87(Pt 10): 2891-2899, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16963747
19.
Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells.
J Immunol
; 177(4): 2208-15, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16887980
20.
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.
J Virol
; 80(24): 12009-16, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17035318